DrugPatentWatch Database Preview

XOLAIR Drug Profile

« Back to Dashboard

Summary for Tradename: XOLAIR

Patents:	87
Applicants:	1
BLAs:	1
Suppliers: see list	1

Pharmacology for XOLAIR

Mechanism of Action	IgE-directed Antibody Interactions
Physiological Effect	Decreased IgE Activity

US Patents for XOLAIR

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Genentech	XOLAIR	omalizumab	VIAL	103976	001	2003-06-20		LegoChem Biosciences, Inc. (Daejeon, KR)		RX		search
Genentech	XOLAIR	omalizumab	VIAL	103976	001	2003-06-20		BIONANOPLUS, S.L. (Noain-Navarra, ES)		RX		search
Genentech	XOLAIR	omalizumab	VIAL	103976	001	2003-06-20		ATOPIX THERAPEUTICS LIMITED (London, GB)		RX		search
Genentech	XOLAIR	omalizumab	VIAL	103976	001	2003-06-20		SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN)		RX		search
Genentech	XOLAIR	omalizumab	VIAL	103976	001	2003-06-20		LegoChem Biosciences, Inc. (Daejeon, KR)		RX		search
Genentech	XOLAIR	omalizumab	VIAL	103976	001	2003-06-20		Banner Life Sciences LLC (High Point, NC)		RX		search

International Patents for XOLAIR

Country	Document Number	Estimated Expiration
Australia	2010266032
European Patent Office	2968549
Norway	20090580
Japan	2010502204
Peru	06432013
European Patent Office	2271364

Supplementary Protection Certificates for XOLAIR

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0822	Netherlands		PRODUCT NAME: RITUXIMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/98/067/003 - UITVOERINGSBESLUIT C(2014)2048 20140326
138	Luxembourg		PRODUCT NAME: RITUXIMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20140326
0753	Netherlands		PRODUCT NAME: TRASTUZUMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826
2015 00043	Denmark		PRODUCT NAME: TRASTUZUMAB OG REKOMBINANT HUMAN HYALURONIDASE; REG. NO/DATE: C(20135603) /EU/1/00/145/002 20130826
2016 00031	Denmark		PRODUCT NAME: RITUXIMAB AND RECOMBINANT HUMAN HYALURONIDASE; NAT. REG. NO/DATE: EU/1/98/067/003-004 20140326; FIRST REG. NO/DATE: EU EU/1/98/067 20140326
2016000049	Germany		PRODUCT NAME: RITUXIMAB UND REKOMBINANTE HUMANE HYALURONIDASE; NAT. REGISTRATION NO/DATE: EU/1/98/067/003 20140321; FIRST REGISTRATION: EU EU/1/98/067/003 20140621